PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 893-901

  Tanwar, Pradeep S ^b   Kaneko Tarui, Tomoko ^a   Lee, Ho Joon ^a   Zhang, LiHua ^a   Teixeira, Jose M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR HOXA10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; ENDOMETRIOID CARCINOMA; FEMALE; GAIN OF FUNCTION MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARIAN ENDOMETRIOID ADENOCARCINOMA; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION; UPREGULATION;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; BETA CATENIN; CARCINOMA, ENDOMETRIOID; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PTEN PHOSPHOHYDROLASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; WNT SIGNALING PATHWAY;

EID: 84875954610     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs405     Document Type: Article

References (56)

1. Cho,K.R. et al. (2009) Ovarian cancer. Annu. Rev. Pathol., 4, 287-313.
2. Bast,R.C. Jr et al. (2009) The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer, 9, 415-428.
3. Aoki,K. et al. (2007) Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J. Cell Sci., 120, 3327-3335.
4. Tanwar,P.S. et al. (2011) Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN. PLoS ONE, 6, e20715.
5. Goss,K.H. et al. (2000) Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol., 18, 1967-1979.
6. Hu,P.J. et al. (2012) Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis. Genes Chromosomes Cancer, 51, 283-289.
7. Galle,T.S. et al. (1999) Causes of death in familial adenomatous polyposis. Scand. J. Gastroenterol., 34, 808-812.
8. Kulkarni,K.P. et al. (2011) Familial adenomatous polyposis with concurrent metastatic appendiceal carcinoid and ovarian cystoadenoma. Pediatr. Blood Cancer, 57, 702-703.
9. Catasus,L. et al. (2004) Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum. Pathol., 35, 1360-1368.
10. Wu,R. et al. (2007) Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell, 11, 321-333.
11. Lague,M.N. et al. (2008) Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis, 29, 2062-2072.
12. You,S. et al. (2006) Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int. J. Exp. Pathol., 87, 227-236.
13. Liang,S. et al. (2009) Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation. PLoS ONE, 4, e4295.
14. Mullany,L.K. et al. (2011) Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene, 30, 3522-3536.
15. Auersperg,N. et al. (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev., 22, 255-288.
16. Cheng,W. et al. (2005) Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat. Med., 11, 531-537.
17. Lane,D.B. et al. (2004) HOXA10 expression in endometrial adenocarcinoma. Tumour Biol., 25, 264-269.
18. Jamin,S.P. et al. (2002) Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet., 32, 408-410.
19. Kuraguchi,M. et al. (2006) Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet., 2, e146.
20. Tanwar,P.S. et al. (2011) Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer. Cancer Res., 71, 1584-1596.
21. Tanwar,P.S. et al. (2010) Constitutive WNT/beta-catenin signaling in murine Sertoli cells disrupts their differentiation and ability to support spermatogenesis. Biol. Reprod., 82, 422-432.
22. Drapkin,R. et al. (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res., 65, 2162-2169.
23. Reya,T. et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
24. Fan,H.Y. et al. (2009) Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells. Cancer Res., 69, 6463-6472.
25. Oshima,M. et al. (1995) Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res., 55, 2719-2722.
26. Faux,M.C. et al. (2004) Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J. Cell Sci., 117, 427-439.
27. Maeda,D. et al. (2011) β-Catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors. Am. J. Surg. Pathol., 35, 1429-1440.
28. Ohishi,Y. et al. (2011) Nuclear localization of E-cadherin but not betacatenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. Histopathology, 58, 423-432.
29. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
30. Harada,N. et al. (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J., 18, 5931-5942.
31. Laury,A.R. et al. (2011) A comprehensive analysis of PAX8 expression in human epithelial tumors. Am. J. Surg. Pathol., 35, 816-826.
32. Miller,C. et al. (1998) Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development, 125, 3201-3211.
33. Crum,C.P. et al. (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin. Med. Res., 5, 35-44.
34. Karst, A M. et al. (2010) Ovarian cancer pathogenesis: a model in evolution. J. Oncol., 2010, 932371.
35. Dubeau, L. (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol., 9, 1191-1197.
36. Dinulescu,D.M. et al. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med., 11, 63-70.
37. Connolly,D.C. et al. (2003) Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res., 63, 1389-1397.
38. Flesken-Nikitin,A. et al. (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res., 63, 3459-3463.
39. Chiang,Y.C. et al. (2008) Synchronous primary cancers of the endometrium and ovary. Int. J. Gynecol. Cancer, 18, 159-164.
40. Tanwar,P.S. et al. (2009) Constitutive activation of beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol. Reprod., 81, 545-552.
41. Roh,M.H. et al. (2010) High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod. Pathol., 23, 1316-1324.
42. Cho,K.R. (2009) Ovarian cancer update: lessons from morphology, molecules, and mice. Arch. Pathol. Lab. Med., 133, 1775-1781.
43. Palacios,J. et al. (1998) Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res., 58, 1344-1347.
44. Memarzadeh,S. et al. (2010) Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proc. Natl Acad. Sci. U.S.A., 107, 17298-17303.
45. Persad,S. et al. (2001) Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol., 153, 1161-1174.
46. Zhao,H. et al. (2005) Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Cancer Res., 65, 6864-6873.
47. Wright,K. et al. (1999) Beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int. J. Cancer, 82, 625-629.
48. Wu,R. et al. (2001) Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res., 61, 8247-8255.
49. Arango,N.A. et al. (2005) Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol., 288, 276-283.
50. Deutscher,E. et al. (2007) Essential roles of mesenchyme-derived beta-catenin in mouse Mullerian duct morphogenesis. Dev. Biol., 307, 227-236.
51. Mericskay,M. et al. (2004) Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development, 131, 2061-2072.
52. Parr,B.A. et al. (1998) Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature, 395, 707-710.
53. Moreno-Bueno,G. et al. (2002) Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene, 21, 7981-7990.
54. Taylor,H.S. et al. (1997) A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol. Reprod., 57, 1338-1345.
55. Bei,L. et al. (2011) HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells. J. Biol. Chem., 286, 19047-19064.
56. Pilon,N. et al. (2006) Cdx4 is a direct target of the canonical Wnt pathway. Dev. Biol., 289, 55-63.